Advertisement

Phytoestrogens as Hormone Replacement Therapy for Postmenopausal Symptoms

  • Susan R. Davis
Part of the Endocrine Updates book series (ENDO, volume 8)

Abstract

Plant constituents with a phenol structure similar to estrogen are known as phyto (plant) estrogens. These compounds, found in a wide variety of edible plants, may display both estrogenic and anti-estrogenic effects. Epidemiological studies, primarily comparing Asian and Western populations, have been interpreted to indicate that consumption of a phytoestrogen-rich diet ameliorates estrogen deficiency symptoms in postmenopausal women, and may protect against breast cancer, bone loss and cardiovascular disease. Consequently there is a global movement towards increased consumption of phytoestrogen rich foods and tablet formulations of concentrated isoflavone extracts are being heavily promoted. More recent intervention studies question the validity of the proposed benefits of phytoestrogen supplementation, with little data in postmenopausal women to support a role for phytoestrogens as an alternative for conventional hormone replacement therapy (HRT).

Keywords

Breast Cancer High Performance Liquid Chromatography Postmenopausal Woman Soybean Isoflavones Vaginal Cytology 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Price KR, Fenwick GR. Naturally occurring oestrogens in foods — a review. Food Addit Comtam 1985; 2: 73406.Google Scholar
  2. 2.
    Wong E. Harborne JB, Mabry TJ, Mabry H, editors.The Flavonoids. New York: Academic Press; 1975; The Isoflavonoids. p. 748–800.Google Scholar
  3. 3.
    Messina M. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr.Cancer 1994; 21: 113–31.PubMedGoogle Scholar
  4. 4.
    Utian WH. Comparative trial of P1496, a new non-steroidal oestrogen analogue. BMJ 1973; 1: 577–83.Google Scholar
  5. 5.
    Axelson M, Kirk D, Farrant RD, Cooley G, Lawson AM, Setchell KDR. The identification of the weak oestrogen equol [7-hydroxy-3-(’hydroxyphenyl)chroman] in human urine. Biochem J 1982; 201: 353–7.PubMedGoogle Scholar
  6. 6.
    Setchell KDR, Adlercreutz H. The excretion of two new phenolic compounds (180/442 and 180/410) during the menstrual cycle and in pregnancy. J Steroid Biochem l979; 11: xvGoogle Scholar
  7. 7.
    Xu X, Wang H-J, Murphy PA, Cook L, Hendrich S. Diadzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J.Nutr. 1994; 124: 825–32.PubMedGoogle Scholar
  8. 8.
    Xu X, Harris KE, Wang H, Murphy PA. Bioavailability of soybean isoflavones depends upon gut microflora in women. J.Nutr. 1995; 125: 2307–15.PubMedGoogle Scholar
  9. 9.
    Tew By, Xu X, Wang H-J, Murphy PA, Hendrich S. A diet high in whnreat fibre decreases the bioavailability of soybean isoflavones in a single meal fed to women. J Nutr 1996; 126: 871–7.PubMedGoogle Scholar
  10. 10.
    Kelly GE, Joannou GE, Reeder AY, Nelson C, Waring MA. The variable metabolic response to dietary isoflavones in humans. Proc Soc Exp Biol Med 1995; 208: 40–3.PubMedGoogle Scholar
  11. 11.
    Kelly G. Patent application number PCT/AU93/000230. Patent Application 1993;Google Scholar
  12. 12.
    Bannwart C, Adlercreutz H, Wahala K, et al. Identifications of the phytoestrogen 31,7dihydroxyisoflavan, an isomer of equol, in human urine and cow’s milk. Biomed Environ Mass Spectrom 1988; 17: 1–6.PubMedGoogle Scholar
  13. 13.
    Setchell KDR, Borriello SP, Gordon GB, et al. Lignan formation in man-microbial involvement and possible roles in relation to cancer. Lancet 1981; 11: 4–7.Google Scholar
  14. 14.
    Axelson M, Setchell KDR. The excretion of lignans in rats–Evidence for an intestinal bacterial source of this new group of compounds. FEBS Lett 1981; 123: 337–42.PubMedGoogle Scholar
  15. 15.
    Adlercreutz H, Fotsis T, Bannwart C, Wahala K, Makela T, Brunow G, Hase T. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J Steroid Biochem 1986; 25: 791–7.PubMedGoogle Scholar
  16. 16.
    Adlercreutz H, Hockerstedt K, Bannwart C, Bloigu S, Hamalainen E. Effect of dietary components, including lignans and phytoestrogens on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem 1987; 27 (4–6): 1135–44.PubMedGoogle Scholar
  17. 17.
    Adlercreutz H, Goldin BR, Gorbach SL. Soybean phytoestrogen intake and cancer risk. J Nutr 1995; 125: 757S - 70S.PubMedGoogle Scholar
  18. 18.
    Morton MS, Wilcox G, Walqvist ML, Griffiths K. Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J Endocr 1994; 142: 251–9.PubMedGoogle Scholar
  19. 19.
    Kirkman LM, Lampe JW, Campbell DR, Martini MC, Slavin JL. Urinary lignan and isoflavone excretion in men and women consuming vegetable and soy diets. Nutr.Cancer 1995; 24 ((1)): 112.Google Scholar
  20. 20.
    Hargreaves DF, Potten CS, Harding C, Shaw LE, Morton MS, Roberts SA, Howell A, Bundred NJ. Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J.Clin Endocrinol Metab 1999; 84 (11): 4017–24.PubMedGoogle Scholar
  21. 21.
    Setchell KDR, Borriello SP, Kirk D, Axelson M. Non-steroidal estrogens of dietary original: possible roles in hormone dependent disease. Am J Clin Nutr. 1984; 40: 569–78.PubMedGoogle Scholar
  22. 22.
    Lu LJ, Anderson KE, Grady JJ. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epid Bio & Prey 1994; 5: 63–70.Google Scholar
  23. 23.
    Hutchins AM, Lampe JW, Martini MC, Campbell DR, Slavin JL. Vegetables fruits and legumes: effects on urinary isoflavonoid phytoestrogen and lignan excretion. J Am Diet Asso 1995; 95 ((7)): 769–74.Google Scholar
  24. 24.
    Axelson M, Sjovall J, Gustafsson BE. Soya–a dietary source of the non-steroidal oestrogen equol in man and animals. J Endocr 1984; 102: 49–56.PubMedGoogle Scholar
  25. 25.
    Knight D, Eden J. Phytoestrogens–a short review. Maturitas 1995; 22: 167–75.PubMedGoogle Scholar
  26. 26.
    Wang H, Murphy PA. Isoflavone content in commercial soybean foods. J Agric Food Chem 1994; 42: 1666–73.Google Scholar
  27. 27.
    Messina M, Messina V. Increasing use of soy foods and their potential role in cancer prevention. J Am Diet Asso 1991; 91: 836–40.Google Scholar
  28. 28.
    Eldridge A. Determination of isoflavones in soybean flours, protein concentrates and isolates. J Agric Food Chem 1982; 30: 353–5.Google Scholar
  29. 29.
    Thompson LU, Robb P, Serraino M. Mammalian lignan production from various foods. Nutr.Cancer 1991; 16 (1): 43–52.PubMedGoogle Scholar
  30. 30.
    Eldridge A, Kwolek WF. Soybean isoflavones: Effect of environment and variety on composition. J Agric Food Chem 1983; 31: 394–6.PubMedGoogle Scholar
  31. 31.
    Ekena K, Katzenellenbogen JA, Katzenellenbogen BS. Determinants of ligand specificity of estrogen receptor-alpha: estrogen versus androgen discrimination. J Biol Chem 1998; 273 (2): 693–9.PubMedGoogle Scholar
  32. 32.
    Montano MM, Katzenellenbogen BS. The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens. Proc Natl Acad Sci USA 1997; 94 (6): 2581–6.PubMedGoogle Scholar
  33. 33.
    Markiewicz L, Garey J, Adlercreutz H, Gurpide E. In vitro bioaccays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol 1993; 45: 399–405.PubMedGoogle Scholar
  34. 34.
    Kuiper GG, Carlson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson J. Comparison of the ligand binding specifity and transcript tissue distribution of estrogen receptors (alpha) and (beta). Endocrinology 1997; 138: 863–70.PubMedGoogle Scholar
  35. 35.
    Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J, Gustaffson JA, Carlquist M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J 1999; 18 (17): 4608–18.PubMedGoogle Scholar
  36. 36.
    Bennets HW, Underwood EJ, Shier FL. A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Aust Vet J 1946; 22: 2–12.Google Scholar
  37. 37.
    Hisaw, F. L., editor. Estrogen-like substances in plants. In psychology of Reproduction: Prceedings of the 22nd Annual Biology Collquium 1961. 1961; Corvallis. USA: Oregon State University Press.; 1963; 140 p.Google Scholar
  38. 38.
    Drane HM, Patterson DSP, Roberts BA. Oestrogenic activity of soya-bean products. Food and Cosmetics Toxicol 1980; 18: 425–7.Google Scholar
  39. 39.
    Adams NR. Masculinisation of the external genitalia in ewes with clover disease. Australian Veterinary Journal 1979; 55: 22–4.PubMedGoogle Scholar
  40. 40.
    Clarke IJ, Scaramuzzi RJ, Short RV. J Embryol.exp.Morph 1976; 36: 87PubMedGoogle Scholar
  41. 41.
    Wang TYY, Sathyamoorthy N, Phang JM. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 1996; 17 (2): 271–5.PubMedGoogle Scholar
  42. 42.
    Sathyamoorthy N, Wang TYY, Phang JM. Stimulation of pS2 expression by diet-derived compounds. Cancer Res. 1994; 54: 957–61.PubMedGoogle Scholar
  43. 43.
    Wang C, Kurzer MS. Phytoestrogen concentrations determines effects on DNA synthesis in human breast cancer cells. Nutr.Cancer 1997; 28 (3): 236–47.PubMedGoogle Scholar
  44. 44.
    Peterson G, Barnes S. Genistein and bichanin A inhibit the gorwth of human prostate cancer cells but not epidermal growth factor receptor tyrosine kinase autophosphorylation. Prostate 1993; 22: 335–45.PubMedGoogle Scholar
  45. 45.
    Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J Nutr 1995; 125: 777S - 83S.PubMedGoogle Scholar
  46. 46.
    Davis SR, Dalais FS, Simpson ER, Murkies AL. Phytoestrogens in Health and disease. Recent Progress in Hormone Research 1999; 54: 185–212.PubMedGoogle Scholar
  47. 47.
    Matsukawa Y, Mami N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, Nishino H, Aoike A. Genistein arrests cell cycle progression at G2-M. Cancer Res. 1993; 53: 1328–31.PubMedGoogle Scholar
  48. 48.
    Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987; 262 (12): 5592–5.PubMedGoogle Scholar
  49. 49.
    Okura A, Arakawa H, Oka H, Yoshinari T, Monden Y. Effect of genistein on topoisomerase activity on the growth of (val 12) Ha-ras-transformed NIH 3T3 cells. Biochem.Biophys.Res.Commun. 1988; 157: 183–9.PubMedGoogle Scholar
  50. 50.
    Kulling SE, Metzler M. Induction of micronuclei, DNA strand breaks and HPRT mutations in cultured Chinese hamster V79 cells by the phytoestrogen coumestrol. Food Chem Toxicol 1997; 35 (6): 605–13.PubMedGoogle Scholar
  51. 51.
    Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewicz Z. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukaemic MOLT-4m and HL-60 cells. Cancer Res. 1992; 52: 6200–8.PubMedGoogle Scholar
  52. 52.
    Fotsis T, Pepper M, Adlercreutz H, Fleishman G, Hase T, Montessano R, Schweigerer L. Genistein, a dietary derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA 1993; 90: 2690–4.PubMedGoogle Scholar
  53. 53.
    Adlercreutz H, Bannwart C, Wahala K. Inhibition of Human aromatase by mammalian lignans and isoflavonoid phytoestrogens. Molec Biol 1993; 44 (2): 147–53.Google Scholar
  54. 54.
    Campbell DR, Kurzer MS. Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J.Steroid Biochem.Molec Blot 1993; 46: 381–8.Google Scholar
  55. 55.
    Evans BA, Griffiths K, Morton MS. Inhibition of 5-alpha reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocr 1995; 147: 295–302.PubMedGoogle Scholar
  56. 56.
    Adlercreutz H. Phytoestrogens: Epidemiology and a possible role in cancer protection. Environ Health Perspect 1995; 103 (Suppl 7): 103–12.PubMedGoogle Scholar
  57. 57.
    Mousavi Y, Adlercreutz H. Genistein is an effective stimulator of SHBG production in Hep-G2 human liver cancer cells and suppresses proliferation of these cells in culture. Steroids 1993; 58: 301–4.PubMedGoogle Scholar
  58. 58.
    Wei HC, Wei LH, Frenkel K, Bowen R, Barnes S. Inhibitor of tumour promoter-induced hydrogen peroxide formation vitro and in vivo by genistein. Nutr.Cancer 1993; 20: 1–12.PubMedGoogle Scholar
  59. 59.
    Braquet P, Senn N, Robin JP. Endogenous lignans a potential endogenous digitalis. J Hypertension 1986; 5S: 161S - 4S.Google Scholar
  60. 60.
    Fisher CR, Greaves K, Parlow AF, Simpson ER. Characterisation of mice deficient in aromatase “ArKO” because of targeted disruption of the cyp 19 gene. Proc Natl Acad Sci USA 1998; 95: 6965–70.PubMedGoogle Scholar
  61. 61.
    Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Nack TM. Cancer of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991; 63: 9636.Google Scholar
  62. 62.
    Serra-Majem L, La Vecchia C, Ribas-Barba L, Prieto-Ramos F, Lucchini F, Ramon JM, Salleras L. Changes in diet and mortality from selected cancers in south Mediterranean countries, 19601989. European Journal of Clinical Nutrition 1993; 47 (Supplement 1): S25 - S34PubMedGoogle Scholar
  63. 63.
    Phipps WR, Martini MC, Lampe JW. Effect of flaxseed ingestion on the menstrual cycle. J Clin Endocrinol Metab 1993; 77: 1215–9.PubMedGoogle Scholar
  64. 64.
    Adlercreutz H. Western diet and wrestem diseases: some hormonal and biochemical mechanisms and associations. Scand J clin Lab Invest 1990; 50 (Suppl 210): 3–23.Google Scholar
  65. 65.
    Martin ME, Haourigui M, Pelissero C, Benassayag C, Nunez EA. Interactions between phytoestrogens and human sex steroid binding protein. Life Sci 1996; 58 (5): 429–36.PubMedGoogle Scholar
  66. 66.
    McMichael-Phillips DF, Harding C, Morton MS. Proceedings from the Second International Symposium in the foie of soy in preventing and treating chronic disease. Proc Sec Int Symp Brussels 1996;Google Scholar
  67. 67.
    Lock M. Ambiguities of aging: Japanese experience and perceptions of menopause. Culture, Medicine & Psychiatry 1986; 10: 23–46.Google Scholar
  68. 68.
    Albery LN. Plenary Lecture. The politics of Menopause. Eighth Congress of the International Menopause Society 3–7 November 1996; A15: 4Google Scholar
  69. 69.
    Wilcox G, Walqvist ML, Burger H. Oestrogenic effects of plant foods of post menopausal women. Br Med J 1990; 301: 905–6.Google Scholar
  70. 70.
    Dalais FS, Rice GE, Wahlqvist ML, Grehan M, Murkies AL, Medley G, et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1998; 1: 124–9.PubMedGoogle Scholar
  71. 71.
    Baird DD, Umbach DM, Lansdell L, Hughes CL, Setchell KDR, Weinberg CR, Haney AF, Wilcox Al, McLachlan JA. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J.Clin Endocrinol Metab. 1995; 80 (5): 1685–90.PubMedGoogle Scholar
  72. 72.
    Murkies AL, Lombard C, Strauss BJG. Dietary flour supplementation decreases postmenopausal hot flushes: effect of soy and wheat. Maturitas 1995; 21: 189–95.PubMedGoogle Scholar
  73. 73.
    Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forum E, De Aloysio D. The effects of dietary soy supplementation on hot flushes. Obstet.Gynecol 1998; 91: 6–11.PubMedGoogle Scholar
  74. 74.
    Knight D, Howes JB, Eden JA. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 1999; 2: 79–84.PubMedGoogle Scholar
  75. 75.
    Baber RJ, Templeman C, Morton T, Kelly GE, West L. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symtoms in women. Climacteric 1999; 2: 85–92.PubMedGoogle Scholar
  76. 76.
    Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Eng J Med 1995; 333: 276–82.Google Scholar
  77. 77.
    Anthony MS, Clarkson TB, Weddle DL. Effect of soy protein phytoestrogens on cardiovascular risk factors in rhesus monkeys. J Nutr 1995; 125 ((3 Suppl)): 803–4.Google Scholar
  78. 78.
    Honore EK, Williams JK, Anthony MS..Soy isoflavones enhance coronary vascular reactivity in athersclerotic female macaques. Fertil Steril 1997; 67 (1): 148–54.PubMedGoogle Scholar
  79. 79.
    Greaves K, Zhang L, Williams K, Parks J, Wagner JD. Phytoestrogen and intact soy protein administrations differ in their effects on plasma lipis and lipidproteins. Proceedings of the Symposium on Phytoestrogen Analytical Methods 1997;Google Scholar
  80. 80.
    Bakhit RM, Klein BP, Essex-Sorlie D. Intake of 25g of soybean protein with or without soybean fibre alters plasma lipids in men with elevated cholesterol concentrations. J Nutr 1994; 124: 2 1322.Google Scholar
  81. 81.
    Sirtori CR, Agradi E, Conti F. Soybean-protein diet in the treatment of typeII hyperlipoproteinaemia. Lancet 1977; 1: 275–7.PubMedGoogle Scholar
  82. 82.
    Eden J, Knight D, Howes JB. A controlled trial of isoflavones for menopausal symptoms. Eighth Congress of the International Menopause Society, Sydney 3–7 Nov 1996 1996; 115Google Scholar
  83. 83.
    Teede HJ, Dalais FS, Kotsopoulos D, et al. Phytoestrogen dietary supplementation improves lipid profiles and blood pressure: a double blind, randomised, placebo-controlled study in men and postmenopausal women. [Abstract] Climacteric 2000; 2: (Supp11)127Google Scholar
  84. 84.
    Burger HG, Dudley EC, Groom NP, Guthrie J, Hopper J, Green A, Dennerstein L. Prospectively measured changes in FSH, oestradiol, testosterone and the dimeric inhibins in relation to final menses. J Clin Endocrinol Metab 1999; 84 (11): 4025–30.PubMedGoogle Scholar
  85. 85.
    Tikkanen MJ, Wahala K, Ojala S, Vihma V, Aldercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci USA 1998; 95 (6): 3106–10.PubMedGoogle Scholar
  86. 86.
    World Health Organisation. World Health Statistics 1992. WHO, Geneva. 1993;Google Scholar
  87. 87.
    Cooper C, Campion G, Melton LJ. Hip fractures in the elderly: a world-wide projection. Osteoporos.Int. 1992; 2: 285–9.PubMedGoogle Scholar
  88. 88.
    Anderson JJB, Garner SC. The effects of phytoestrogens on bone. Nutrition Research 1997; 17 (10): 1617–32.Google Scholar
  89. 89.
    Arjmandi BH, Alekel L, Hollis BW. Dietary soybean protein prevents bone loss in an ovarectomized rat model of osteoporosis. J Nutr 1996; 126: 161–7.PubMedGoogle Scholar
  90. 90.
    Agnusdei D, Adami S, Cervetti R, Crepaldi G, Dimunno O, et al. Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosis. Bone Min. 1992; 19: S43 - S48Google Scholar
  91. 91.
    Erdman JW, Stillman RJ, Lee KF. Short term effects of soybean isoflavones on bone in postmenopausal women. [Abstract] Proc Sec Int Symp on the Role of Soy in Preventing and Treating Chronic Disease 1996 1996; 1:Google Scholar
  92. 92.
    Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, Genasni AR. Effects of combined low dose of the isoflavone derivative ipriflavone and estrogen replacement on bone mineral density and metabolism in postmenopausal women. Maturitas 1997; 28: 75–81.PubMedGoogle Scholar
  93. 93.
    Rose DP, Boyar AP, Wynder EL. International comparison of mortality rates for cancer of the breast, ovary, prostate and colon and per capita food consumption. Cancer 1986; 58: 2363–71.PubMedGoogle Scholar
  94. 94.
    Baghurst PA, Rohan TE. High-fibre diets and reduced risk of breast cancer. Int J Cancer 1994; 56: 173–6.PubMedGoogle Scholar
  95. 95.
    Hunter DJ, Spiegelman D, Adami H. Cohort studies of fat intake and the risk of breast cancer–a pooled analysis. N Eng J Med 1996; 334: 356–61.Google Scholar
  96. 96.
    Hirayama T. A large scale cohort study on cancer risks by diet - with special reference to the risk reducing effects of green-yellow vegetable consumption. Diet Nutrition Cancer, Y.Hayashi et al.(Eds) 1986; Japan Sci.Soc.Press, Tokyo-Sci.Press, Utrecht(1986): 41–53.Google Scholar
  97. 97.
    Lee HP, Gourley L, Duffy SW. Dietary effects on breast cancer risk in Singapore. Lancet 1991; 337: 1197–200.PubMedGoogle Scholar
  98. 98.
    Yuan JM, Wang QS, Ross RK, Henderson BE, Yu MC. Diet and breast cancer in Shanghai and Tianjin, China. Br J Cancer 1995; 71: 1353–8.PubMedGoogle Scholar
  99. 99.
    Lawson JS, Field AS, Champion S, Tran D, Ishikura H, Trichopoulos D. Low oestrogen receptor alpha expression in normal breast tissue underlies low breast cancer incidence in Japan. The Lancet 1999; 354: 1787–8.Google Scholar
  100. 100.
    Ingram D, Sanders K, Kolybaby M, Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997; 350: 990–4.PubMedGoogle Scholar
  101. 101.
    Murkies AL, Dalais FS, Healy DL, Burger HG, Wahlqvist ML, Davis SR. Phytoestrogens and endogenous sex steroids in Australian women with and without breast cancer. Climacteric 1999; in pressGoogle Scholar
  102. 102.
    Barnes S, Grubbs C, Setchell KDR, Carlson J. Soy beans inhibit mammary tumours models of breast cancer. Prog Clin Biol Res. 1991; 347: 239–53.Google Scholar
  103. 103.
    Lamartiniere CA, Moore JB, Holland M. Neonatal genistein chemoprevents mammary cancer. Proc Soc Exp Biol Med 1995; 208 (1): 120–3.PubMedGoogle Scholar
  104. 104.
    Lamartiniere CA, Moore JB, Brown NM, Thompson R, Hardin MJ, Barnes S. Genistein suppresses mammary cancer in rats. Carcinogenesis 1995; 16 (11): 2833–40.PubMedGoogle Scholar
  105. 105.
    Murrill WB, Brown NM, Zhang JX, Manzolillo PA, Barnes S, Lamartiniere CA. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 1996; 17: 1451–7.PubMedGoogle Scholar
  106. 106.
    Martin MP, Horwitz KB, Ryan DS. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 1978; 103: 1860–7.PubMedGoogle Scholar
  107. 107.
    Schwartz JA, Liu G, Brooks SC. Genistein-mediated attenuation of tamoxifen-induced antagonism from estrogen receptor-regulated genes. Biochem Biophys Res Commun 1998; 253 (1): 38–43.PubMedGoogle Scholar
  108. 108.
    Tazuke S, Khaw K-T, Chir MBB, Barrett-Connor E. Exogenous estrogen and endogenous sex hormones. Medicine 1992; 71: 44–51.PubMedGoogle Scholar
  109. 109.
    Katzenellenbogen JA. The structural pervasiveness of estrogeniv activity. Environ Health Perspect 1995; 103 (Suppl 7): 99–101.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2000

Authors and Affiliations

  • Susan R. Davis
    • 1
  1. 1.The Jean Hailes FoundationMelbourneAustralia

Personalised recommendations